Reducing Lung CongestIon Symptoms in Advanced Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 605 participants.

Also called NCT03499236

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 605 participants (enrolled count) (from the registry)
Sponsor
V-Wave Ltd (from the registry)
Registry
  • NCT NCT03499236
Other papers using this trial's data
  • Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial Circulation, 2024-12-10 DOI, PubMed 39308371, PMC11627316 In the PMC Open Access subset under CC BY-NC-ND.
  • Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs HFpEF: The RELIEVE-HF Trial JACC. Cardiovascular imaging, 2026-01 DOI, PubMed 40892630

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Belgium, Canada, Germany, Israel, Netherlands, New Zealand, Poland, Spain, Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03499236. Randomized; quadruple masking; primary purpose treatment. Start 2018-09-19 (actual); primary completion 2023-10-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reducing Lung CongestIon Symptoms in Advanced Heart Failure
Acronym
RELIEVE-HF
Condition
Heart Failure
Intervention (Device)
V-Wave Interatrial Shunt
Intervention (Other)
Control
Lead sponsor
V-Wave Ltd (class: industry)

Record details

Record id
cardio:ct-nct03499236
Content hash
93ad51219e71cc9951960ede1924eb9394538e1e17e24cc46b2b52688a99abee